Network pharmacology analysis and experimental validation of modified Taohong Siwu decoction against atherosclerosis

Chen L, Zheng SY, Yang CQ, Ma BM, Jiang D (2019) Mir-155-5p inhibits the proliferation and migration of VSMCs and HUVECs in atherosclerosis by targeting AKT1. Eur Rev Med Pharmacol Sci 23(5):2223–2233. https://doi.org/10.26355/eurrev_201903_17270

Article  CAS  PubMed  Google Scholar 

Cheng Y, Li J, Feng X, Wu Y, Wu X, Lau BWM, Ng SSM, Lee SM-Y, Seto S-W, Leung GP-H, Hu Y, Fu C, Zhang S, Zhang J (2024) Taohong siwu decoction enhances the chemotherapeutic efficacy of doxorubicin by promoting tumor vascular normalization. Phytomedicine 134:155995. https://doi.org/10.1016/j.phymed.2024.155995

Article  CAS  PubMed  Google Scholar 

Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol, 47(8 Suppl):C7–C12. https://doi.org/10.1016/j.jacc.2005.09.068

Fang S, Sun S, Cai H, Zou X, Wang S, Hao X, Wan X, Tian J, Li Z, He Z, Huang W, Liang C, Zhang Z, Yang L, Tian J, Yu B, Sun B (2021) IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1+/- mice display increases atherosclerotic plaque stability. Theranostics 11(19):9358–9375. https://doi.org/10.7150/thno.62797

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fengjin C, Peng Z, Guoying LI, Weizhi Z, Yanyan Z, Daiyin P, Guangliang C (2024) Taohong siwu decoction ameliorates atherosclerosis in rats possibly through toll-like receptor 4/myeloid differentiation primary response protein 88/nuclear factor-κB signal pathway. J Tradit Chin Med 44(1):103–112. https://doi.org/10.19852/j.cnki.jtcm.20231215.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finney DJ (1948) The Fisher-Yates test of significance in 2X2 contingency tables. Biometrika 35(Pts 1-2):145–56

Flora GD, Nayak MK (2019) A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des 25(38):4063–4084. https://doi.org/10.2174/1381612825666190925163827

Article  CAS  PubMed  Google Scholar 

Frostegård J (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med 11:117. https://doi.org/10.1186/1741-7015-11-117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez E, McGraw TE (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell cycle (Georgetown, Tex.) 8(16):2502–2508. https://doi.org/10.4161/cc.8.16.9335

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(25):e1046–e1081. https://doi.org/10.1161/CIR.0000000000000624

Article  PubMed  Google Scholar 

Hao Q, Aertgeerts B, Guyatt G, Bekkering GE, Vandvik PO, Khan SU, Rodondi N, Jackson R, Reny J-L, Al Ansary L, Van Driel M, Assendelft WJJ, Agoritsas T, Spencer F, Siemieniuk RAC, Lytvyn L, Heen AF, Zhao Q, Riaz IB, Ramaekers D, Okwen PM, Zhu Y, Dawson A, Ovidiu MC, Vanbrabant W, Li S, Delvaux N (2022) PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. BMJ 377:e069066. https://doi.org/10.1136/bmj-2021-069066

Article  PubMed  Google Scholar 

Jialal I, Fuller CJ (1995) Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 11 Suppl G:97G–103G

Jing J, Zhu C, Gong R, Qi X, Zhang Y, Zhang Z (2023) Research progress on the active ingredients of traditional Chinese medicine in the intervention of atherosclerosis: a promising natural immunotherapeutic adjuvant. Biomed Pharmacother 159:114201. https://doi.org/10.1016/j.biopha.2022.114201

Article  CAS  PubMed  Google Scholar 

Khan SU, Yedlapati SH, Lone AN, Hao Q, Guyatt G, Delvaux N, Bekkering GET, Vandvik PO, Riaz IB, Li S, Aertgeerts B, Rodondi N (2022) PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ 377:e069116. https://doi.org/10.1136/bmj-2021-069116

Article  PubMed  Google Scholar 

Kim J-Y, Shim SH (2019) Epimedium koreanum extract and its flavonoids reduced atherosclerotic risk via suppressing modification of human HDL. Nutrients. https://doi.org/10.3390/nu11051110

Article  PubMed  PubMed Central  Google Scholar 

Li C, Liu Y, Xie Z, Lu Q, Luo S (2015) Stigmasterol protects against Ang II-induced proliferation of the A7r5 aortic smooth muscle cell-line. Food Funct 6(7):2266–2272. https://doi.org/10.1039/c5fo00031a

Article  CAS  PubMed  Google Scholar 

Li R, Yang Y, Hong P, Zhang Z, Li L, Hui J, Zheng X (2020) β-Carotene attenuates weaning-induced apoptosis via inhibition of PERK-CHOP and IRE1-JNK/p38 MAPK signalling pathways in piglet jejunum. J Anim Physiol Anim Nutr (Berl) 104(1):280–290. https://doi.org/10.1111/jpn.13216

Article  CAS  PubMed  Google Scholar 

Liang Y-J, Yang W-X (2019) Kinesins in MAPK cascade: how kinesin motors are involved in the MAPK pathway? Gene 684:1–9. https://doi.org/10.1016/j.gene.2018.10.042

Article  CAS  PubMed  Google Scholar 

Liang YT, Wong WT, Guan L, Tian XY, Ma KY, Huang Y, Chen Z-Y (2011) Effect of phytosterols and their oxidation products on lipoprotein profiles and vascular function in hamster fed a high cholesterol diet. Atherosclerosis 219(1):124–133. https://doi.org/10.1016/j.atherosclerosis.2011.06.004

Article  CAS  PubMed  Google Scholar 

Luo Z-R, Li H, Xiao Z-X, Shao S-J, Zhao T-T, Zhao Y, Mou F-F, Yu B, Guo H-D (2019) Taohong Siwu decoction exerts a beneficial effect on cardiac function by possibly improving the microenvironment and decreasing mitochondrial fission after myocardial infarction. Cardiol Res Pract 2019:5198278. https://doi.org/10.1155/2019/5198278

Article  PubMed  PubMed Central  Google Scholar 

Luo N, Fang J, Wei L, Sahebkar A, Little PJ, Xu S, Luo C, Li G (2021) Emodin in atherosclerosis prevention: pharmacological actions and therapeutic potential. Eur J Pharmacol 890:173617. https://doi.org/10.1016/j.ejphar.2020.173617

Article  CAS  PubMed  Google Scholar 

Luo Z-R, Meng W-T, Li H, Wang Y, Wang Y-C, Zhao Y, Lu P-P, Yuan Y, Huang W, Guo H-D (2024) Transplantation of induced pluripotent stem cells-derived cardiomyocytes combined with modified Taohong Siwu decoction improved heart repair after myocardial infarction. Heliyon 10(4):e26700. https://doi.org/10.1016/j.heliyon.2024.e26700

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen M-R, Tokgozoglu L, Wiklund O (2020) 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188. https://doi.org/10.1093/eurheartj/ehz455

Article  PubMed  Google Scholar 

Meng T, Li X, Li C, Liu J, Chang H, Jiang N, Li J, Zhou Y, Liu Z (2022a) Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways. Front Pharmacol 13:997598. https://doi.org/10.3389/fphar.2022.997598

Meng W, Zhongxin X, Han L, Yachao W, Yue Z, Yan Z, Haihong G (2022b) Modified Taohong Siwu decoction improves cardiac function after myocardial ischaemia and reperfusion in rats by promoting endogenous stem cell mobilization and regulating metabolites. Pharm Biol 60(1):1721–1731. https://doi.org/10.1080/13880209.2022.2116054

Rotllan N, Wanschel AC, Fernández-Hernando A, Salerno AG, Offermanns S, Sessa WC, Fernández-Hernando C (2015) Genetic evidence supports a major role for Akt1 in VSMCs during atherogenesis. Circ Res 116(11):1744–1752. https://doi.org/10.1161/CIRCRESAHA.116.305895

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shao C-L, Cui G-H, Guo H-D (2022) Effects and mechanisms of Taohong Siwu decoction on the prevention and treatment of myocardial injury. Front Pharmacol 13:816347. https://doi.org/10.3389/fphar.2022.816347

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shao C-l, Meng W-T, Wang Y-C, Liu J-J, Ning K, Hou X-X, Guo H-D (2024) Regulating NETs contributes to a novel antiatherogenic effect of MTHSWD via inhibiting endothelial injury and apoptosis. Int Immunopharmacol 143(Pt 2):113368. https://doi.org/10.1016/j.intimp.2024.113368

Article  CAS  PubMed  Google Scholar 

Simion V, Zhou H, Pierce JB, Yang D, Haemmig S, Tesmenitsky Y, Sukhova G, Stone PH, Libby P, Feinberg MW (2020) LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling. JCI Insight. https://doi.org/10.1172/jci.insight.140627

Article  PubMed  PubMed Central  Google Scholar 

Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, Fowkes FGR, Fowkes FJI, Rudan I (2020) Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health 8(5):e721–e729. https://doi.org/10.1016/S2214-109X(20)30117-0

Article  PubMed 

Comments (0)

No login
gif